Biosimilars, and High Value Molecules

Biosimilars, and High Value Molecules

Products
Biosimilars, and High Value Molecules
Biosimilars, and High Value Molecules

Information

Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules. We are looking for reputable global partners who want to expand their product line and in-license for their territory.
Distribution Areas
North America (USA, Canada)Middle East Region (e.g. UAE)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
United States
All categories
Biopharmaceutical ProductsBiosimilarsAntibody Drug Conjugates (ADCs)Products
Main Categories
Biopharmaceutical Products
Lodaat PharmaLODAAT Pharma is a USA firm with a portfolio of high value molecules including Biosimilars, Biologics, Rare Disease, Orphan Drugs. Our consumer health group is renowned for innovation in OTC in all major therapeutic categories including pain management, inflammation and gut microbiome. We are a leading investor in innovator drugs, ADCs, NCEs and new drug development for oncology, immunology, diabetes, cardiovascular, and other therapeutics. We look for leading global partners for out-licensing and want to expand their portfolios. www.Lodaatpharma.com

Log in

See all the content and easy-to-use features by logging in or registering!